A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 68
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CG
Long Form : chlorhexidine gluconate
No. Year Title Co-occurring Abbreviation
2020 Development of Capsular Fibrosis Beneath the Liver Surface in Humans and Mice. CF, TGF-beta1
2020 Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis. 3-DZNeP, EZH2, HPMCs, PD, PDF
2020 Materials Sealing Preventing Biofilm Formation in Implant/Abutment Joints: Which Is the Most Effective? A Systematic Review and Meta-Analysis. CR, GP, PTFE
2019 Connective tissue growth factor is correlated with peritoneal lymphangiogenesis. HPMCs, PD, TGF-beta1, VEGF-C
2019 Delayed administration of suramin attenuates peritoneal fibrosis in rats. EGFR, STAT3, TGF-beta1
2019 Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats. i.p, PD, PF, PM, rBMP7, TAM
2018 A high-density collagen xerogel thread prevents the progression of peritoneal fibrosis. CTGF, CXT, TGF
2018 Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation. cKO
2018 Itraconazole Attenuates Peritoneal Fibrosis Through Its Effect on the Sonic Hedgehog Signaling Pathway in Mice. i.p, SHH
10  2017 Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model. EPS, i.p, IS, MMP-2, PD, TGF-beta1
11  2017 Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis. HDACi, PD, PF, PM, VPA
12  2017 Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis. CTGF, GFP, PF, PMCs
13  2016 Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-kappaB activation. CS, NF
14  2016 Evaluation for Peritoneal Injury at an Early Stage Using Dual Macromolecular Markers. FD, MGO, PD
15  2016 In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species. BEC, CSH, DAS
16  2015 Chlorhexidine gluconate versus povidone iodine at cesarean delivery: a randomized controlled trial. CD, PI
17  2015 Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis. CH, i.p
18  2015 Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis Model. EPS, FA, MGO, PD
19  2015 Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis. MCs, WT1
20  2015 Optimal Irrigation and Debridement of Infected Total Joint Implants with Chlorhexidine Gluconate. CFUs, MRSA, PJI
21  2015 Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats. alpha-SMA, AST, IL-1beta, MCP-1, PF, ROS, TGF-beta, TNF-alpha
22  2015 SAHA Suppresses Peritoneal Fibrosis in Mice. SAHA
23  2015 Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORgammat transgenic mice. PF, Tg, Th
24  2015 The kampo medicine Daikenchuto inhibits peritoneal fibrosis in mice. alpha-SMA, DKT, HSP 47
25  2015 Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells. EMT, MCs, PD, TGF-beta1
26  2014 Adipose-derived mesenchymal stem cells transplantation facilitate experimental peritoneal fibrosis repair by suppressing epithelial-mesenchymal transition. ASCs, EMT, PDGF-BB, PF, VEGF
27  2014 Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis. alpha-SMA, CGA, DNMT1, EPS, FSP1, PCR, RASAL1, SD, TGF-beta
28  2014 Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair. PD, TGF, TSMCs, VEGF
29  2014 Suramin inhibits the development and progression of peritoneal fibrosis. IkappaB, NF, PD, TGF-beta1
30  2014 The postantifungal effect and phospholipase production of oral Candida albicans from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to subtherapeutic concentrations of chlorhexidine gluconate. PAFE
31  2013 22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model. MCP-1, NF-kappaB, OCT, TGF-beta, VDR
32  2013 Involvement of leptin in the progression of experimentally induced peritoneal fibrosis in mice. ---
33  2013 Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice. 3,4-DGE, alpha-SMA, GDPs, PD
34  2013 Role of tyrosine kinase inhibition with imatinib in an encapsulating peritoneal sclerosis rat model. EPS, i.p, TGF-beta1
35  2012 Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes. MAPK
36  2012 Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model. BM, GFP, PF
37  2012 Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model. EPS, HE
38  2012 Interaction of antimicrobial preservatives with blow-fill-seal packs: correlating sorption with solubility parameters. BA, BFS, BKC, CBL, LDPE, PP
39  2012 Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model. PD, SCID, WT
40  2012 Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-beta, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis. EPS, MMPs, PIO, PPARs, TGF-beta, TIMP
41  2012 Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. ---
42  2011 Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats. i.p, LC, PD
43  2011 Sairei-to ameliorates rat peritoneal fibrosis partly through suppression of oxidative stress. HNE, SOD
44  2011 Thalidomide prevents the progression of peritoneal fibrosis in mice. PCNA, TGF, VEGF
45  2010 Comparative susceptibility of Salmonella Typhimurium biofilms of different ages to disinfectants. ---
46  2010 Rechargeable infection-responsive antifungal denture materials. CADS, PMAA
47  2009 Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis? EPS, i.p, NAC, ROS, UF
48  2009 Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis? AZT, EPS, GC, i.p, IS
49  2009 Erythropoietin suppresses peritoneal fibrosis in rat experimental model. EPO, PD
50  2009 Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. ---
51  2009 Tissue factor and factor v involvement in rat peritoneal fibrosis. ---
52  2008 Development of a peritoneal sclerosis rat model using a continuous-infusion pump. alpha-SMA, EPS, TGF-beta1, VEGF
53  2008 Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model. EPS, i.p, mTOR, UF
54  2008 Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. ---
55  2008 Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model. EPS, i.p, PD, PET, PPARs, UF, WBC
56  2008 The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis. EPS, i.p
57  2008 The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis. EPS, i.p, PD, RAS, UF
58  2007 Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. PD, VEGF
59  2004 TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. CDK2, HSP47, ICR, PCNA, PD, VEGF
60  2003 Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. alpha-SMA, CAPD, HSP47, ODNs
61  2003 Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. ASMA, HSP-47
62  2001 [Comparison of four protocols for preoperative preparation in cattle]. CFU, PI
63  1999 Different responses of planktonic and attached Bacillus subtilis and Pseudomonas fluorescens to sanitizer treatment. PAH, SEM
64  1996 Chlorhexidine gluconate versus chloroxylenol for preoperative skin preparation in dogs. CFU, RODAC
65  1991 A comparison of the effects of two antiseptic agents on Staphylococcus epidermidis colony forming units at the peritoneal dialysis catheter exit site. CFU, P-I, PD, S. epi
66  1991 Reduced bacteria on transplantable allograft skin after preparation with chlorhexidine gluconate, povidone-iodine, and isopropanol. ---
67  1990 Comparison of three skin preparation techniques in the dog. Part 1: Experimental trial. CFUs, PI, RODAC
68  1990 Comparison of three skin preparation techniques. Part 2: Clinical trial in 100 dogs. PI, RODAC